Literature DB >> 32454054

NLRP3 inflammasome-dependent pyroptosis and apoptosis in hippocampus neurons mediates depressive-like behavior in diabetic mice.

Dong-Xia Li1, Chang-Nan Wang2, Yan Wang3, Chang-Lin Ye4, Lai Jiang5, Xiao-Yan Zhu6, Yu-Jian Liu7.   

Abstract

A relatively large number of diabetic patients risk complications of clinical depression that lead to poorer quality of life, however the precise mechanisms for diabetes-associated depression are not fully understood. Links between hyperglycemia-induced oxidative stress and NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) inflammasome activation have been reported in the pathogenesis of diabetes. The present study aimed to elucidate the contribution of NLRP3-mediated apoptotic/pyroptotic neuronal cell death to diabetes-associated depression. We found that depressive-like behavior in streptozotocin (STZ)-induced diabetic mice was associated with hippocampal NLRP3 inflammasome activation. Hyperglycemia increased reactive oxygen species (ROS) production, thus leading to NLRP3 inflammasome activation in hippocampal neurons. It was found that STZ treatment induced apoptotic and pyroptotic cell death in the hippocampus as evidenced by increases of cleaved caspase 3 positive hippocampal neurons, TUNEL-positive cells, protein levels of p53, Bax, Puma, and the cleaved GSDMD N-terminal fragment, all of which were decreased in NLRP3 deficient mice. Using murine hippocampal neuronal cell line HT22, we found that high glucose induced apoptotic and pyroptotic cell death in a NLRP3 inflammasome-dependent manner in vitro. In addition, NLRP3 deficiency alleviated depressive-like behavior in STZ-induced diabetic mice. Our results suggest that hyperglycemia results in apoptosis and pyroptosis of hippocampal neuron cells in a NLRP3-dependent manner, which was associated with the depressive phenotypes evoked by STZ-induced diabetes. The study identifies a novel function of NLRP3 activation in high glucose-induced neuronal cell death, which sheds further light on the pathogenesis and new therapeutic targets of diabetes-associated depression.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Depression; Diabetes; NLRP3; Pyroptosis

Year:  2020        PMID: 32454054     DOI: 10.1016/j.bbr.2020.112684

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  14 in total

Review 1.  Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases.

Authors:  Jennifer M Erichsen; Jim R Fadel; Lawrence P Reagan
Journal:  Neuropharmacology       Date:  2021-11-08       Impact factor: 5.250

2.  Salidroside Ameliorates Depression by Suppressing NLRP3-Mediated Pyroptosis via P2X7/NF-κB/NLRP3 Signaling Pathway.

Authors:  Yuhui Chai; Yawen Cai; Yu Fu; Yingdi Wang; Yiming Zhang; Xue Zhang; Lingpeng Zhu; Mingxing Miao; Tianhua Yan
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

Review 3.  Molecular prospect of type-2 diabetes: Nanotechnology based diagnostics and therapeutic intervention.

Authors:  Rout George Kerry; Gyana Prakash Mahapatra; Ganesh Kumar Maurya; Sushmita Patra; Subhasis Mahari; Gitishree Das; Jayanta Kumar Patra; Sabuj Sahoo
Journal:  Rev Endocr Metab Disord       Date:  2020-10-14       Impact factor: 6.514

Review 4.  Mechanism of Ferroptosis and Its Relationships With Other Types of Programmed Cell Death: Insights for Potential Interventions After Intracerebral Hemorrhage.

Authors:  Sheng-Yu Zhou; Guo-Zhen Cui; Xiu-Li Yan; Xu Wang; Yang Qu; Zhen-Ni Guo; Hang Jin
Journal:  Front Neurosci       Date:  2020-11-13       Impact factor: 4.677

Review 5.  NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation.

Authors:  Zhilei Wang; Guang Xu; Zhiyong Li; Xiaohe Xiao; Jianyuan Tang; Zhaofang Bai
Journal:  J Inflamm Res       Date:  2022-01-19

6.  Knockdown of TRIM8 Protects HK-2 Cells Against Hypoxia/Reoxygenation-Induced Injury by Inhibiting Oxidative Stress-Mediated Apoptosis and Pyroptosis via PI3K/Akt Signal Pathway.

Authors:  Bang-Hua Zhang; Hao Liu; Yan Yuan; Xiao-Dong Weng; Yang Du; Hui Chen; Zhi-Yuan Chen; Lei Wang; Xiu-Heng Liu
Journal:  Drug Des Devel Ther       Date:  2021-12-10       Impact factor: 4.162

7.  Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer's Disease (sAD) Mouse Model.

Authors:  Valentina Latina; Giacomo Giacovazzo; Pietro Calissano; Anna Atlante; Federico La Regina; Francesca Malerba; Marco Dell'Aquila; Egidio Stigliano; Bijorn Omar Balzamino; Alessandra Micera; Roberto Coccurello; Giuseppina Amadoro
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

8.  Transcriptional Profiles Reveal Deregulation of Lipid Metabolism and Inflammatory Pathways in Neurons Exposed to Palmitic Acid.

Authors:  M Flores-León; N Alcaraz; M Pérez-Domínguez; K Torres-Arciga; R Rebollar-Vega; I A De la Rosa-Velázquez; C Arriaga-Canon; L A Herrera; Clorinda Arias; Rodrigo González-Barrios
Journal:  Mol Neurobiol       Date:  2021-06-21       Impact factor: 5.590

9.  Rapid Eye Movement Sleep Deprivation Combined With Fluoxetine Protects Against Depression-Induced Damage and Apoptosis in Rat Hippocampi via A1 Adenosine Receptor.

Authors:  Xuan Ju; Shengdong Wang; Pan Yan; Chunyan Zhu; Xiwen Hu; Jiezheng Dong; Zhonglin Tan
Journal:  Front Psychiatry       Date:  2021-07-16       Impact factor: 4.157

Review 10.  Inflammasomes as therapeutic targets in human diseases.

Authors:  Yangxin Li; Hui Huang; Bin Liu; Yu Zhang; Xiangbin Pan; Xi-Yong Yu; Zhenya Shen; Yao-Hua Song
Journal:  Signal Transduct Target Ther       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.